Takashi Hisabe
Overview
Explore the profile of Takashi Hisabe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsumoto T, Hisamatsu T, Esaki M, Omori T, Sakuraba H, Shinzaki S, et al.
Dig Endosc
. 2025 Mar;
PMID: 40025935
In recent years, we have seen a considerable increase in the number of patients with inflammatory bowel diseases of unknown etiology, including both Crohn's disease and ulcerative colitis. Inflammatory bowel...
2.
Hiratsuka Y, Hisabe T, Ohtsu K, Yasaka T, Takeda K, Miyaoka M, et al.
J Anus Rectum Colon
. 2025 Jan;
9(1):79-87.
PMID: 39882222
Objectives: Colonoscopy is the gold standard for screening cancer and precancerous lesions in the large intestine. Recently, remarkable advances in artificial intelligence (AI) have led to the development of various...
3.
Kinjo K, Aoki T, Kobayashi K, Yamauchi A, Yamada A, Omori J, et al.
Gastrointest Endosc
. 2024 Nov;
PMID: 39557205
Background And Aims: We sought to validate the British Society of Gastroenterology (BSG) guidelines for acute lower GI bleeding (ALGIB). Methods: We analyzed 8956 patients with ALGIB in the Colonic...
4.
Fukuyama A, Nakashima A, Miyazaki M, Fujiki M, Kakimoto H, Hisabe T, et al.
J Pharm Health Care Sci
. 2024 Oct;
10(1):65.
PMID: 39425179
Background: The therapeutic landscape for ulcerative colitis (UC) has recently broadened to include anti-TNFα, anti-integrin, and anti-IL-12/23p40 antibody agents. These biological agents are tailored to individual patient profiles. However, some...
5.
Kobayashi T, Moriya K, Fujii T, Bamba S, Shinzaki S, Yamada A, et al.
Intest Res
. 2024 Jul;
PMID: 39004512
Background/aims: Bowel urgency is an important symptom for quality of life determination in patients with ulcerative colitis (UC). Few clinical studies have focused on bowel urgency as an efficacy endpoint....
6.
Ito S, Hotta K, Sekiguchi M, Takeuchi Y, Oka S, Yamamoto H, et al.
Dig Endosc
. 2023 Nov;
36(8):942-951.
PMID: 37986226
Objectives: The incidence of colorectal neuroendocrine tumors (NETs) has increased with colorectal cancer screening programs and increased colonoscopies. The management of colorectal NETs has recently shifted from radical surgery to...
7.
Hirai M, Yanai S, Kunisaki R, Nishio M, Watanabe K, Sato T, et al.
Gastrointest Endosc
. 2023 Jun;
98(5):806-812.
PMID: 37263363
Background And Aims: Patients with ulcerative colitis (UC) are at risk of developing colorectal cancer. The feasibility of endoscopic resection (ER) for UC-associated neoplasia has been suggested, but its efficacy...
8.
Hasegawa R, Yao K, Kanemitsu T, Arima H, Hirase T, Hiratsuka Y, et al.
Clin Endosc
. 2023 May;
57(1):65-72.
PMID: 37157963
Background/aims: Multiple white and flat elevated lesions (MWFL) that develop from the gastric corpus to the fornix may be strongly associated with oral antacid intake. Therefore, this study aimed to...
9.
Nemoto D, Guo Z, Katsuki S, Takezawa T, Maemoto R, Kawasaki K, et al.
Gastrointest Endosc
. 2023 Feb;
98(1):90-99.e4.
PMID: 36738793
Background And Aims: Differentiation of colorectal cancers (CRCs) with deep submucosal invasion (T1b) from CRCs with superficial invasion (T1a) or no invasion (Tis) is not straightforward. This study aimed to...
10.
Nakase H, Wagatsuma K, Nojima M, Matsumoto T, Matsuura M, Iijima H, et al.
J Gastroenterol
. 2023 Jan;
58(3):205-216.
PMID: 36607399
Background: Given the increasing health concerns for patients with inflammatory bowel disease (IBD), amidst the COVID-19 pandemic, we investigated the impact of the pandemic on the anxiety and behavioral changes...